Medical Equipment

Point Of Care Lipid Test Market Forecast With Insights On Demand And Industry Growth

April 15, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Point Of Care Lipid Test Market Between 2026 And 2030?

The point of care lipid test market has shown substantial growth in recent years. Its value is anticipated to rise from $0.74 billion in 2025 to $0.82 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. The market’s past expansion is credited to factors such as the increasing prevalence of cardiovascular diseases, the demand for swift testing, advancements in biosensor technology, greater understanding of cholesterol management, and the accessibility of point-of-care devices.

The point of care lipid test market is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $1.17 billion, growing at a compound annual growth rate (CAGR) of 9.4%. The impetus behind this growth during the forecast period stems from various factors including integration with mobile applications and cloud platforms, expansion into home care environments, increasing adoption within clinics and hospitals, the development of multi-analyte tests, and strategic collaborations between device and software providers. Furthermore, significant trends shaping the forecast period include fingerstick lipid testing, the availability of portable lipid analyzers, the use of multi-parameter analyzers, advancements in rapid cardiovascular risk assessment, and the rise of home-based lipid monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/point-of-care-lipid-test-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Point Of Care Lipid Test Market?

The escalating incidence of cardiovascular diseases is anticipated to fuel the expansion of the point of care lipid test market moving forward. Cardiovascular diseases are defined as conditions impacting the heart and blood vessels, including coronary artery disease, stroke, and hypertension, often resulting from atherosclerosis linked to imbalanced cholesterol and triglyceride levels. The increasing prevalence of these diseases is a consequence of more sedentary lifestyles and reduced physical activity, which contribute to obesity, poor circulation, and other factors predisposing individuals to CVDs. Point-of-care lipid tests are instrumental in addressing the rising occurrence of cardiovascular diseases by enabling quick, on-site assessment of cholesterol and other lipid levels, thereby allowing for prompt risk identification and timely therapeutic interventions to prevent disease worsening. For instance, in January 2024, the American Heart Association, a US-based nonprofit organization, stated that fatalities due to cardiovascular disease in the cardiovascular sector reached 931,578, indicating a rise of 3,000 deaths compared to the previous year’s figure of 928,741. Thus, the increasing prevalence of cardiovascular diseases is expected to propel the growth of the point of care lipid test market.

How Is The Point Of Care Lipid Test Market Broken Down By Segment Categories?

The point of care lipid test market covered in this report is segmented –

1) By Product Types: Instruments, Consumables

2) By Application: Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Familial Hypercholesterolemia, Other Applications

3) By End-User: Hospitals, Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Instruments: Portable Or Handheld Analyzers, Multi-parameter Analyzers, Single-parameter Analyzers

2) By Consumables: Test Strip, Reagents And Kits

Which Trends Are Shaping The Point Of Care Lipid Test Market?

Key players within the point-of-care lipid test market are prioritizing innovative solutions, such as sophisticated point-of-care (POC) diagnostic platforms, to supply rapid, accurate, and lab-quality lipid panel results directly at the patient’s bedside, thereby enhancing clinical decision-making and overall patient management. An advanced point-of-care (POC) diagnostic platform is characterized as a portable, integrated device that conducts swift, precise, and high-quality tests close to the patient, facilitating real-time clinical judgments and immediate health interventions. For example, in July 2023, Vital Biosciences Inc., a Canada-based health technology company, introduced VitalOne, a point-of-care lab testing platform. This platform is engineered to deliver over 50 lab-grade blood test results within just 20 minutes, using a compact, automated device in locations such as clinics and pharmacies. The system combines hematology, clinical chemistry, and immunoassays into one instrument, empowering healthcare providers to manage testing, diagnosis, and treatment in a single visit, profoundly improving access, speed, and personalized patient care, all with accuracy comparable to traditional central laboratories.

Which Players Are Present In The Point Of Care Lipid Test Market Space?

Major companies operating in the point of care lipid test market are Abbott Laboratories, EKF Diagnostics Holdings plc, Roche Diagnostics International AG, Siemens Healthineers AG, Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, EKF Diagnostics USA Inc., VivaChek Biotech (Hangzhou) Co. Ltd., Menarini Diagnostics S.r.l., Trinity Biotech plc, AccuBioTech Co. Ltd., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited, SD Biosensor Inc., ARKRAY Inc., PTS Diagnostics, HemoCue AB, MedTest Dx Inc., Nova Biomedical Corporation

Get The Full Point Of Care Lipid Test Market Report:

https://www.thebusinessresearchcompany.com/report/point-of-care-lipid-test-global-market-report

Where Is The Point Of Care Lipid Test Market Primarily Concentrated By Region?

North America was the largest region in the point of care lipid test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care lipid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Point Of Care Lipid Test Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/point-of-care-lipid-test-global-market-report

Browse Through More Reports Similar to the Global Point Of Care Lipid Test Market 2026, By The Business Research Company

Low Density Lipoprotein Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

Lipid Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Cholesterol Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795